AREZOU PETRIE, RPH
Pharmacy at Grove Ave, Rancho Cucamonga, CA
License number
California 48122
Category
Pharmacy
Type
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Address
Address
2
8283 Grove Ave STE 105, Rancho Cucamonga, CA 91730
PO Box 572227, Los Angeles, CA 91357
PO Box 572227, Los Angeles, CA 91357
Phone
(909) 981-0956
(818) 632-3797
(818) 632-3797
Personal information
See more information about AREZOU PETRIE at radaris.comName
Address
Phone
3208 Palos Verdes Ln, Palos Verdes Peninsula, CA 90274
4516 Petit Ave, Encino, CA 91436
8038 Oakdale Ave, Winnetka, CA 91306
Professional information
Travel Consultant At Advantage Vaccination
Position:
PHARMACIST at PARKVIEW PHARMACY, TRAVEL CONSULTANT at ADVANTAGE VACCINATION
Location:
Greater Los Angeles Area
Industry:
Pharmaceuticals
Work:
PARKVIEW PHARMACY
since Jul 2005
-
PHARMACIST
ADVANTAGE VACCINATION
- RANCHO CUCAMONGA since Jul 2005
-
TRAVEL CONSULTANT
Education:
Saint John's University 1986 - 1992
Rph, Pharmacist
Rph, Pharmacist
Skills:
Pharmaceutical Industry, New Business Development, Healthcare, Clinical Trials, Contract Negotiation, Biotechnology, Hospitals, Clinical Research, Market Analysis, Marketing Strategy, Sales Management, Marketing
Transdermal Treatment Device And Method
US Patent:
2009015, Jun 18, 2009
Filed:
Sep 5, 2008
Appl. No.:
12/231798
Inventors:
Arezou Petrie - Tarzana CA, US
Louis Petrie - Tarzana CA, US
Xavier Roy - Tarzana CA, US
Louis Petrie - Tarzana CA, US
Xavier Roy - Tarzana CA, US
International Classification:
A61M 35/00, A61K 31/5513, A61K 9/00, A61K 9/70, A61K 9/127, A61K 39/08
US Classification:
604 22, 514221, 424400, 424449, 424450, 4242361, 604290, 604310
Abstract:
A treatment device for treating a medical condition comprises a composition selected for its ability to treat the medical condition, the composition being formulated for transdermal delivery. A portable container is provided which comprises a body for accommodating the composition in a sealed arrangement, a frangible seal on the container which can be ruptured to enable discharge of the composition from the body, and an application component on the container for facilitating transdermal delivery of the composition.